{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T08:51:45Z","timestamp":1784796705925,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["2023-10-001"],"award-info":[{"award-number":["2023-10-001"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["3-2023-0246"],"award-info":[{"award-number":["3-2023-0246"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ijantimicag.2024.107212","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T20:03:34Z","timestamp":1716494614000},"page":"107212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Shifting trends in bloodstream infection-causing microorganisms and their clinical impact in patients with haematologic malignancies in South Korea: A propensity score-matched study"],"prefix":"10.1016","volume":"64","author":[{"given":"Heekang","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9801-9874","authenticated-orcid":false,"given":"Min Hyuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dokyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Hoon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2024.107212_bib0001","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","article-title":"Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey","volume":"21","author":"Trecarichi","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0002","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cmi.2015.01.029","article-title":"Factors influencing mortality in neutropenic patients with haematologic malignancies or solid tumours with bloodstream infection","volume":"21","author":"Mar\u00edn","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0003","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/374339","article-title":"Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States","volume":"36","author":"Wisplinghoff","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0004","doi-asserted-by":"crossref","first-page":"e51612","DOI":"10.1371\/journal.pone.0051612","article-title":"Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality","volume":"7","author":"Tumbarello","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0005","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1086\/322604","article-title":"Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients","volume":"33","author":"Collin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0006","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.blre.2008.10.003","article-title":"Bloodstream infections in haematology: risks and new challenges for prevention","volume":"23","author":"Worth","year":"2009","journal-title":"Blood Rev"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0007","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJM199909163411207","article-title":"Fever in immunocompromised patients","volume":"341","author":"Pizzo","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0008","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s11899-013-0171-4","article-title":"Febrile neutropenia in hematologic malignancies","volume":"8","author":"Keng","year":"2013","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0009","series-title":"Open forum infectious diseases","first-page":"ofac240","article-title":"Bloodstream infections in hematologic malignancy patients with fever and neutropenia: are empirical antibiotic therapies in the United States still effective?","author":"Zimmer","year":"2022"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0010","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10096-013-1819-7","article-title":"Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance","volume":"32","author":"Montassier","year":"2013","journal-title":"Eur J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0011","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/QCO.0000000000000038","article-title":"Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact","volume":"27","author":"Trecarichi","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0012","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1473-3099(19)30755-8","article-title":"Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study","volume":"20","author":"Van Duin","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0013","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00277-018-3341-6","article-title":"Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria","volume":"97","author":"Cattaneo","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0014","unstructured":"Centers for Disease Control and Prevention. National Healthcare Safety Network (NHSN) Patient Safety Component Manual. CDC; 2023. Available from: https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/pcsmanual_current.pdf."},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0015","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","article-title":"Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia","volume":"353","author":"Bucaneve","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0016","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","article-title":"Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients","volume":"19","author":"Gudiol","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0017","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(16)30514-X","article-title":"Effects of control interventions on Clostridium difficile infection in England: an observational study","volume":"17","author":"Dingle","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.900681","article-title":"Risk factors of severe Clostridioides difficile infection; sequential organ failure assessment score, antibiotics, and ribotypes","volume":"13","author":"Choi","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0019","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1086\/383048","article-title":"Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens","volume":"39","author":"Ramphal","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106886","article-title":"Changes in the prevalence of pathogens causing hospital-acquired bacterial pneumonia and the impact of their antimicrobial resistance patterns on clinical outcomes: a propensity-score-matched study","volume":"62","author":"Choi","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0021","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/23744235.2017.1347814","article-title":"Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol\u2014a prospective nationwide study","volume":"49","author":"Kolonen","year":"2017","journal-title":"Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0022","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1182\/hematology.2020000098","article-title":"Updates in infection risk and management in acute leukemia","volume":"2020","author":"Logan","year":"2020","journal-title":"Hematology"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0023","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1139\/m92-116","article-title":"Capsules of Escherichia coli, expression and biological significance","volume":"38","author":"Jann","year":"1992","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0024","doi-asserted-by":"crossref","first-page":"e13186","DOI":"10.1111\/tid.13186","article-title":"Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: results from a multicentric surveillance cohort study","volume":"21","author":"Kern","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0025","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0026","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00277-019-03607-z","article-title":"Bloodstream infections with vancomycin-resistant enterococci are associated with a decreased survival in patients with hematological diseases","volume":"98","author":"Weber","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0027","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ajh.24489","article-title":"Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey","volume":"91","author":"Trecarichi","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0028","first-page":"4057","article-title":"Bloodstream infection caused by S. aureus in patients with cancer: a 10-year longitudinal single-center study","volume":"26","author":"Bello-Chavolla","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijantimicag.2024.107212_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224465","article-title":"Bloodstream infections caused by Escherichia coli in onco-haematological patients: risk factors and mortality in an Italian prospective survey","volume":"14","author":"Trecarichi","year":"2019","journal-title":"PLoS One"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924001304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924001304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:43:55Z","timestamp":1778766235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857924001304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0924857924001304"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107212","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shifting trends in bloodstream infection-causing microorganisms and their clinical impact in patients with haematologic malignancies in South Korea: A propensity score-matched study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107212"}}